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Impaired Coordination of Nutrient Intake and Substrate
Oxidation in Melanocortin-4 Receptor Knockout Mice
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JIANPING YE, ANTHONY W. BANNON, WILLIAM G. RICHARDS, AND ANDREW A. BUTLER
Pennington Biomedical Research Center/Louisiana State University (D.C.A., J.M., R.L.M., J.Y., A.A.B.), Baton Rouge,
Louisiana 70808; Department of Biological Sciences (J.M.S.), Louisiana State University, Baton Rouge, Louisiana 70803;
and Amgen Inc. (A.W.B., W.G.R.), Thousand Oaks, California 91320
Mutations in the melanocortin-4 receptor (MC4R) are associ-
ated with obesity. The obesity syndrome observed in humans
with MC4R haploinsufficiency is similar to that observed in
MC4R knockout mice, including increased longitudinal
growth, hyperphagia, and fasting hyperinsulinemia. For com-
parison with other commonly investigated models of obesity
and insulin resistance, we have backcrossed Mc4r/ mice
into the C57BL/6J (B6) background. Female obese Mc4r/
mice exhibit reduced energy expenditure and an attenuated
increase in fatty acid (FA) oxidation after exposure to high-fat
diets compared with obese Lepob/Lepob mice. The reduced en-
ergy expenditure and FA oxidation correlates with changes in
hepatic gene expression. The expression of genes involved in
FA oxidation increased in obese Lepob/Lepob mice compared
with wild-type and obese Mc4r/ mice. In contrast, a key
lipogenic enzyme, FA synthase (FAS), is increased in obese
Mc4r/ mice compared with obese Lepob/ Lepob mice. Hyper-
insulinemia, increased FAS mRNA expression and hepatic ste-
atosis appear to be secondary to obesity in B6 Mc4r/ mice.
However, Mc4r/ mice in a mixed genetic background de-
velop severe hepatic steatosis at an early age. This might sug-
gest an important role of the MC4R in regulating liver FA
metabolism that is masked on the B6 background. Interest-
ingly, the 10- to 20-fold increase in liver triglyceride in the
outbred strain of Mc4r/ mice is not always associated with
fasting hyperinsulinemia or increased FAS mRNA expression.
This observation suggests that changes in liver secondary to
triglyceride accumulation lead to hyperinsulinemia and in-
creased hepatic FAS expression in Mc4r/ mice. (Endocri-
nology 145: 243–252, 2004)
THE CURRENT EPIDEMIC of obesity and type 2 diabetesmellitus (DM2), if unchecked, will place a considerable
strain on the health care system (1, 2). The obesity epidemic
is likely due to a combination of genetic and environmental
factors (3). Analysis of the development of DM2 in inbred
mouse strains, in conjunction with studies of humans, sug-
gest that genetic variation is involved in determining the
frequency of obesity and DM2 subjects (3, 4).
A reduction in metabolic rate and fatty acid (FA) oxidation,
perhaps associated with low sympathetic nervous activity,
are thought to increase the risk of developing obesity and
associated pathologies such as diabetes and cardiovascular
disease (5). To date, the most commonly found single gene
mutation discovered to be associated with obesity occurs in
the melanocortin-4 receptor (MC4R) gene (6–10). Although
hyperphagia is a significant factor in obesity because of
MC4R haploinsufficiency (11), the results of pair-feeding
studies in mouse models indicate that, in the adult mouse,
metabolic factors might also contribute to the obese pheno-
type of MC4R-deficient subjects (12).
The MC4R is expressed in areas of the central nervous
system that regulate the activity of neuroendocrine and au-
tonomic systems (13–15). Consistent with neuroanatomical
evidence supporting a role for the MC4R in regulating au-
tonomic activity, Mc4r/ mice exhibit an attenuated ther-
mogenic response to hyperphagia (16, 17) and to the stim-
ulation of renal sympathetic nervous activity by leptin,
insulin, and the nonspecific melanocortin agonist MTII (18).
MC4R are also required for the increase in oxygen consump-
tion (VO2) and suppression of food intake by MTII (19, 20).
In the paraventricular nucleus of the hypothalamus, MC4R
mRNA is expressed in thyroid-releasing hormone (TRH) (15)
and corticotropin-releasing factor (CRF) neurons (21). Acti-
vation of MC4R on TRH neurons in the paraventricular nu-
cleus of the hypothalamus stimulates TRH synthesis and
increases T3 and T4 levels in the circulation (15, 22, 23).
Activation of MC4R expression on CRF neurons increases
CRF transcription and circulating corticosterone levels (21).
Mc4r/ mice on a mixed 129;B6 background rapidly de-
veloped insulin resistance, with fasting hyperglycemia and hy-
perinsulinemia (12, 24, 25). We have now backcrossed the null
Mc4r allele onto the C57BL/6J (B6) background, which will
facilitate the comparison of the phenotype of Mc4r/ mice
with other transgenic and spontaneous mutant models of DM2.
In this article, we describe the results of studies using indirect
calorimetry and gene expression analysis to examine metabo-
Abbreviations: ACC, Acetyl-coenzyme A carboxylase; AOX, acyl-
coenzyme A oxidase; B6, C57BL/6J; BSw;129, Black Swiss [NIHNTac:
NIH(S)-Tyrp1,Tyr];129; CPT1a, carnitine palmitoyltransferase; CRF,
corticotropin-releasing factor; DGAT, acyl-coenzyme A:diacylglycerol
acyltransferase; DM2, type 2 diabetes mellitus; EE, energy expenditure;
FA, fatty acid; FAS, fatty acid synthase; FFM, fat-free mass; FM, fat mass;
FQ, food quotient; IRS, insulin receptor substrate; MC4R, melanocortin-4
receptor; NEFA, nonesterified fatty acid; NMR, nuclear magnetic res-
onance; PPAR, peroxisome proliferator receptor; PRCF, percent cumu-
lative frequency; RER, respiratory exchange ratio; SREBP, sterol regu-
latory element binding protein; TG, triglyceride; TRH, thyroid-releasing
hormone; VO2, oxygen consumption; WT, wild-type.
Endocrinology is published monthly by The Endocrine Society (http://
www.endo-society.org), the foremost professional society serving the
endocrine community.
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lism of Mc4r/ and Lepob/Lepob mice. Mice were continuously
housed in the metabolic chambers and fed purified diets. Sur-
prisingly, our data indicate that obese Mc4r/ mice have a
lower energy expenditure (EE), adjusted for fat-free mass
(FFM), when compared with Lepob/Lepob mice. In older obese
mice, the expression of genes involved in FA oxidation, carni-
tine palmitoyltransferase (CPT1a), and acyl-coenzyme A oxi-
dase (AOX) is increased in liver of Lepob/Lepob mice compared
with both lean wild-type (WT) and obese Mc4r/ mice. In
contrast, the expression of a key lipogenic gene, FA synthase
(FAS), is 3-fold higher in older obese Mc4r/ mice compared
with Lepob/Lepob mice. Mc4r/ mice on the B6 background
develop hepatic steatosis and insulin resistance similar to that
observed in Lepob/Lepob mice, which is secondary to obesity. On
a mixed genetic background, Mc4r/ mice develop severe
hepatic steatosis before the onset of obesity. This could indicate
an important role for the MC4R in regulating liver metabolism
that is masked on the B6 background.
Materials and Methods
Experimental animals
All studies were reviewed and approved by the Pennington Biomed-
ical Research Center Institutional Animal Care and Use Committee. In
experiment 1, we examined EE and estimated substrate oxidation [re-
spiratory exchange ratio (RER)] in obese female Mc4r/ and Lepob/Lepob
mice on the B6 background. All mutant mice were generated using
heterozygote parents and were genotyped as previously described (16,
26). Lepob/Lepob mice were derived from a colony of B6.V-Lepob mice
purchased from Jackson Laboratories (Bar Harbor, ME). WT refers to B6
mice derived from the Mc4r/ and B6.V-Lepob breeding colonies. Fat
mass (FM) and FFM were determined in triplicate by nuclear magnetic
resonance (NMR) using a Bruker Mice Minispec NMR Analyzer (Bruker
Optics Inc., Billerica, MA).
In experiment 2, we analyzed gene expression in preobese Mc4r/
mice. For this experiment, Mc4r/ mice on two genetic backgrounds were
used. We examined gene expression in Mc4r/ mice on the B6 back-
ground and in Mc4r/ mice derived from an outbred colony on a Black
Swiss [NIHNTac:NIH(S)-Tyrp1,Tyr];129 background (BSw;129).
Three purified diets using lard and soybean oil as the source of fat
were purchased from Research Diets, Inc. (New Brunswick, NJ). The
low-fat diet [catalog no. D12450B, 15.9 kJ/g, food quotient (FQ)  0.925]
had 10% kJ from fat, 70% kJ from carbohydrate, and 20% kJ from protein.
The high-fat diet (catalog no. D12451, 19.7 kJ/g, FQ  0.823) had 45%
kJ from fat, 35% kJ from carbohydrate, and 20% kJ from protein. The very
high-fat diet had 60% kJ from fat and 20% kJ from carbohydrate and
protein (catalog no. D12492, 21.8 kJ/g, FQ  0.781).
Indirect calorimetry
Indirect calorimetry was performed, as described previously, using
a 16-chamber Oxymax system (Columbus Instruments, Columbus, OH)
(16, 27). Mice were housed on a 12 h light and dark cycle (dark 0100–1300
h, light 1300–0100 h) at 28 C. Mice were allowed 5–7 d to acclimate to
the novel environment with free access to food, which was placed on the
wire mesh at the bottom of the chamber, and water. Plastic tubing was
supplied to minimize stress associated with housing on wire mesh.
EE (kJ/h) was calculated using VO2 (VO2  [3.815  (1.232  RER)] 
4.1868). Percent energy from substrate oxidation (F%, C%) was esti-
mated using the RER (28), and the balance was then calculated by
subtracting total kJ of substrate oxidized from the amount ingested over
the 3-d period. RER, VO2, and EE data were analyzed as bins of either
4 h or as dark and light periods.
Percent relative cumulative frequency (PRCF) curves were calculated
as described previously (29). The analysis of PRCF curves is a recently
developed method used to evaluate calorimetry data. To calculate the
PRCF curves for VO2, EE, and RER, data sets from mutant or WT mice
were pooled, and the cumulative frequency calculated in Microsoft Excel
(Microsoft Corporation, Redmond, WA). The advantage of this method
is that it allows for the comparison of the range of metabolic data
between groups. For VO2 and EE, this provides an easy visual method
for comparing metabolic rate between low (corresponding to resting
metabolic rate) and high (activity-based EE) values. Differences in basal
metabolic rate, affecting VO2 and EE throughout the diurnal cycle, are
predicted to result in a parallel shift of the S-shaped cumulative fre-
quency curve. On the other hand, differences in activity-based EE would
be predicted to affect the curve in the upper quartile only.
Triglyceride (TG), glucose, insulin, and FA measurements. Total lipid content of
liver was quantitated using a chloroform-methanol extraction (30), and
tissue TG content was determined as described previously (31). Commer-
cially available kits were used to determine serum insulin (CrystalChem
Inc., Downers Grove, IL) and TG (GPO-Trinder; Sigma-Aldrich Corp., St.
Louis, MO). Venous blood glucose levels were measured from tail-vein
blood sample using a Glucometer Elite (Bayer Corp., Elkhart, IN).
RNA expression analysis
Total RNA, extracted from tissues using TRI Reagent, was kept in
Rnase-free formazol (Molecular Research Center, Inc., Cincinnati, OH).
Quantitation of mRNA expression, using cyclophilin B as a standard,
was performed using an ABI Prism 7700 HT sequence detection system
(Applied Biosystems, Foster City, CA) as described previously (32). The
primers and probes for cyclophilin B and peroxisome proliferator re-
ceptor (PPAR)  have been described previously (29, 33). Primer and
probe combinations were designed using the genomic sequence ob-
tained from the National Center for Biotechnology Information [gene
and accession no.: AOX, AF006688; L-CPT1a, AF17175; FAS, AF127033;
FA translocase/CD36, NM007643, sterol regulatory element binding
protein (SREBP) 1, AF374266]. All primer-probe combinations were
designed to span introns to minimize signals arising from RNA template
and genomic DNA contamination.
Gel electrophoresis and immunoblotting
Frozen tissue was homogenized in a buffer containing 150 mm NaCl, 10
mm Tris (pH 7.4), 1 mm EGTA, 1 mm EDTA, 1% Triton X-100, 0.5% Nonidet
P-40, 1 m phenylmethylsulfonylfluoride, 1 m pepstatin, 50 trypsin in-
hibitory mU of aprotinin, 10 m leupeptin, and 2 mm sodium vanadate.
Homogenates were centrifuged for 10 min at 5000 rpm to remove any
debris and insoluble material and then analyzed for protein content.
Protein extracts were separated in 5%, 7.5%, 10%, or 12% polyacryl-
amide (acrylamide from National Diagnostics, Atlanta, GA) gels con-
taining sodium dodecyl sulfate (SDS) and transferred to nitrocellulose
(Bio-Rad Laboratories, Hercules, CA) in 25 mm Tris, 192 mm glycine, and
20% methanol. After transfer, the membrane was blocked in 4% milk for
1 h at room temperature. Mouse monoclonal antibodies to FAS were
purchased from BD Transduction Laboratories (Lexington, KY). Poly-
clonal antibodies to SREBP 1, PPAR, insulin receptor substrate (IRS) 2,
and p65 were purchased from Santa Cruz Biotechnology Inc. (Santa
Cruz, CA). The SREBP1 antibody was raised against the N-terminal
domain of SREBP1 and, thus, recognizes both the full-length mature
protein (p125) and the N-terminal nuclear fragment of SREBP1 (p68).
Acetylcoenzyme A carboxylase (ACC)  and  were detected as de-
scribed previously (34). Results were visualized with horseradish per-
oxidase (HRP)-conjugated secondary antibodies (Sigma) and enhanced
chemiluminescence (Pierce, Rockford, IL).
Statistics
All data presented are mean  sem. Statistical analysis of studies com-
paring genotype and diet used a two-way ANOVA, with diet and genotype
as variables, followed by all pair-wise multiple comparison procedures
(Student-Newman-Keuls test). Statistical analysis used the SigmaStat Soft-
ware for Windows version 2.03 (SPSS Inc., Chicago, IL). For studies com-
paring two groups, statistical analysis used the Student’s t test.
Results
Experiment 1: analysis of metabolism in obese
Mc4r/ mice
Body weight and food intake data. Lepob/Lepob mice are temper-
ature sensitive and exhibit signs of distress when housed in
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wire-bottom cages at standard room temperatures (20–25 C);
therefore, we maintained temperature at a constant 28 C.
Female Mc4r/ (n  8), Lepob/Lepob (n  10), and WT con-
trols (n  8), aged 2.5–3.5 months of age, were individually
housed and fed the low-fat purified diet (D12450B, 10% kJ
from fat) for 1 month. The mice were then acclimated to the
metabolic chambers for 5–7 d. FM and FFM were measured
3 h after the end of the dark period on the first day of the
experiment, after 3 d on the low-fat diet, and again after 3 d
on the high-fat diet (D12451, 45% kJ from fat; Table 1). Lepob/
Lepob mice had increased body weight due to more FM,
whereas, for Mc4r/ mice, increased body weight was due
to more FM and FFM (FFM: WT, 14.8  0.2 g; Lepob/Lepob,
15.9  0.6 g; Mcr4/, 19.1  0.6 g; P  0.01 compared with
WT and Lepob/Lepob; FM: WT, 1.9  0.2 g; Lepob/Lepob, 20.3 
1.3 g; Mcr4/, 11.3  1.1 g; P  0.01 between all groups).
Energy intake data, total and adjusted for FFM, are shown
in Table 1. Hyperphagia in Mc4r/ mice was affected by
dietary fat content, as reported previously using chow diets
(16, 17). Although high-fat diets are normally expected to
induce hyperphagia, we have observed an initial 20% re-
duction in energy consumption using diet D12451 in other
experiments. Moreover, chronic exposure to diet D12451,
unlike very high-fat diets, does not induce hyperphagia in
longer term studies (35).
Comparison of EE in obese Mc4r/ and Lepob/Lepob mice. In
previous experiments examining EE of Mc4r/ mice, re-
cordings were limited to a short period in the light cycle (16).
We were also not able to compensate for the greater meta-
bolic activity of lean tissues compared with adipose (36), with
VO2 and EE data not adjusted for FFM. In the present study,
we obtained EE data over several days, allowing us to ex-
amine the diurnal variation. VO2 and EE exhibited a grossly
normal circadian rhythm irrespective of genotype or diet
(Fig. 1, A and B). As reported by others (37), obesity asso-
ciated with leptin deficiency (Lepob/Lepob) was associated with
higher EE adjusted for lean mass. However, obese Mc4r/
mice appeared to have normal EE. Analysis using two-way
ANOVA indicated significant effects of diet (P  0.05) and
genotype (P  0.05), with least square means for VO2 and EE
listed in Table 2.
Comparison of the PRCF curves for VO2 and EE reveal
that, when fed the low-fat diet, the largest differences be-
tween strain occur in the upper quartile range (Fig. 2, A and
C). After the introduction of the high-fat diet, the difference
in the PRCF curves of VO2 and EE for WT and Mc4r/ mice
became more noticeable, again in the upper quartile range
(Fig. 2, B and D). This is consistent with the observation that
the major differences in the increase of VO2 and EE of
Mc4r/ mice compared with WT and Lepob/Lepob mice occur
during the lights-off phase (Fig. 1, C and D). This observation
is also consistent with lower peak VO2 and EE values for
Mc4r/ mice during the early phase of the dark cycle,
observed upon careful observation of the diurnal rhythm
(Fig. 1, A and B), and with the differences in diet-induced
thermogenesis, which were greatest during the lights-off
cycle (Fig. 1, C and D). This might indicate differences in
activity-based EE or perhaps the thermic effect of feeding of
Mc4r/ mice compared with WT mice. The right shift of the
curve of Lepob/Lepob mice compared with WT and Mc4r/
mice occurs over the total curve, perhaps indicating changes
in basal metabolic rate.
The lower metabolic rate of Mc4r/ mice relative to
Lepob/Lepob mice is an intriguing and unexpected observation.
It is possible that the increased EE of obese Lepob/Lepob mice
compared with obese Mc4r/ mice represents an adaptive
TABLE 1. Body weight and food intake data for mice housed in metabolic chamber fed either an LF diet (10% kJ/fat, 20% kJ/protein, and
70% kJ/carbohydrate) or HF diet (45% kJ/fat, 20% kJ/protein, and 35% kJ/carbohydrate)
WT Mc4r/ Lepob/Lepob
Weight (g)
Basal 21.5  0.6 35.6  1.1 40.8  1.8
D 3, LF 22.5  0.7 36.1  1.1 42.1  1.6
D 6, HF 22.1  0.6 37.2  1.1 42.4  1.5
FM % total body weight
Basal 10.1  1.1 33.8  1.5 47.3  1.8
D 3, LF 11.4  0.9 35.3  1.2 51.3  1.6
D 6, HF 11.0  0.8 37.1  1.3 51.4  1.0
Energy intake per animal (kJ/d)
LF diet 53  4a 63  3b 74  4c
HF diet 41  2a 74  5b 60  2c
Energy intake (kJ/g FFMd)
LF diet 3.6  0.3a 3.3  0.2a 4.7  0.3b
HF diet 2.8  0.1a 3.8  0.2b 3.9  0.2b
Two-way ANOVA: kJ/d (P) kJ/g FFMd (P)
Genotype 0.001 0.001
Diet 0.001 0.058
Genotype  diet 0.005 0.01
LF, Low-fat; HF, high-fat.
Mice were weighed and body composition determined by NMR on the first day of the study (basal), after 3 d on the LF diet (d 3), and after
3 d on the HF diet (d 6). Energy consumption data for mice housed in the metabolic chambers fed LF diet (10% kJ/fat, 20% kJ/protein, and
70% kJ/carbohydrate) or HF diet (45% kJ/fat, 20% kJ/protein, and 35% kJ/carbohydrate). Total energy consumption (kJ/d) was measured by
weighing food every third day. Energy consumption was also adjusted for lean mass (kJ/g FFMd), which was significantly higher in Mc4r/
mice compared with WT and Lepob/Lepob mice. a,b Statistical analysis used two-way ANOVA and an all pair-wise multiple comparison procedure;
all values within diet that do not share a common letter are significantly different (P  0.05). Food intake on the LF and HF diets within genotype
was significantly different in WT and Lepob/Lepob mice (P  0.01).
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response to weight gain that has been reported in humans
(38). The attenuated increase in EE of obese Mc4r/ mice
could, therefore, indicate a role for this receptor in the in-
creased EE associated with obesity. Alternatively, a thresh-
old level of obesity required to increase EE might not have
been achieved in Mc4r/ mice, which were not as obese as
the Lepob/Lepob mice (34–37% vs. 47–51% body fat, respec-
tively; Table 1).
Substrate oxidation of female obese WT, Mc4r/, and Lepob/Lepob
mice fed purified low-fat and high-fat diets ad libitum. For the 3 d on
the low-fat diet, RER was stable and was not affected by ge-
notype (mean RER over 3 d: WT, 0.984  0.016; Lepob/Lepob,
0.988  0.011; Mc4r/, 0.990  0.021; Fig. 3A). Introduction
of the high-fat diet was associated with a decline in the RER
irrespective of genotype. However, the mean RER over the 3 d
on the high-fat diet was significantly higher in Mc4r/ mice
(RER: Mc4r/, 0.859  0.012; Lepob/Lepob, 0.830  0.011; WT,
0.804  0.007; post hoc analysis: Mc4r/ vs. WT, P  0.01;
Mc4r/ vs. Lepob/Lepob, P  0.059; Lepob/Lepob vs. WT, P 
0.088). The difference in the RER of Mc4r/ mice fed the
high-fat diet compared with both WT and Lepob/Lepob mice was
maximal between 24 and 48 h after the introduction of the
high-fat diet (Fig. 3A). During the dark period of d 2 on the
high-fat diet, the RER of Mc4r/ mice was significantly higher
than WT and Lepob/Lepob mice (P  0.05).
The ratio of RER to the FQ indicates the balance of nutrient
intake and oxidation and must be balanced over the long
term to maintain a constant body weight (39, 40). Energy
stored as glycogen is rapidly depleted when compared with
the far greater amount of energy stored in the form of TG. It
has been proposed that, therefore, it is more important to
maintain a balance between carbohydrate consumption and
oxidation (39, 40). In these experiments, the RER to FQ ratio
correlated with the change in weight on the high-fat diet (Fig.
3, C and D). On the low-fat diet, the RER to FQ ratio was
greater than 1 irrespective of genotype, and all mice gained
weight. On the high-fat diet, the RER to FQ ratio declined to
FIG. 2. PRCF of VO2 (A, B) and heat (C, D) of WT, Mc4r/, and
Lepob/Lepob mice on low-fat (LF) (A, C) or high-fat (HF) (B, D) diets.
Each curve represents the cumulative frequency of 800-1200 data
points for eight WT, eight Mc4r/, or 10 Lepob/Lepob mice.
TABLE 2. Least squares means of VO2 and EE for Mc4r/,
Lepob/Lepob, and WT controls during the lights-on and lights-
off cycles
WT Mc4r/ Lepob/Lepob
VO2 (liters/kg of FFMh)
Lights on 5.0  0.2 4.9  0.2 5.5  0.1a
Lights off 5.7  0.2 5.4  0.2 6.0  0.1a
EE (kJ/kg of FFMh)
Lights on 101  4 97  4 111  3a
Lights off 116  4 112  4 124  4a
The data represent the mean  SEM of measurements for 3 d on the
low-fat diet and 3 d on the high-fat diet.
a P  0.05 compared with Mc4r/.
FIG. 1. Attenuated increase in VO2 and heat of Mc4r/ mice, rel-
ative to WT and Lepob/Lepob mice, in response to high-fat (HF) diet.
Analysis of the data pooled as 4-h bins showed that the circadian
rhythm in VO2 (A) and EE (B) was not affected by genotype, with peak
values occurring at the beginning of the dark phase. Introduction of
the HF diet resulted in an increase in VO2 and EE. To calculate the
rate of increase, data from the light and dark periods were pooled and
the percent increase calculated for each period for VO2 (C) and EE (D).
The percent increase in VO2 and EE was lower in Mc4r/ mice,
especially in the dark period on d 1 of exposure to the HF diet. *, P 
0.05 compared with WT and Lepob/Lepob. LF, Low-fat.
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less than 1 in WT and Lepob/Lepob mice for long periods.
However, the RER to FQ ratio remained greater than 1 in
Mc4r/ mice fed the high-fat diet. Mc4r/ mice gained
significantly more weight than WT mice on the high-fat diet
(P  0.01).
The balance of substrate intake and oxidation during high-fat
feeding was estimated by calculating the percent of total energy
derived from FA oxidation (F%) using the RER (28) (Fig. 3E).
The results of the analysis of fat and carbohydrate balance (kJ
consumed  kJ oxidized) during the period on the high-fat diet
indicate that carbohydrate intake and oxidation were balanced
irrespective of genotype. In contrast, fat balance correlated with
the RER to FQ ratio and weight gain data (compare Fig. 3E with
Fig. 3, C and D), with only Mc4r/ mice exhibiting a positive
fat balance on the high-fat diet. Overall, the data are consistent
with tightly regulated carbohydrate oxidation and consump-
tion, with differences in weight gain correlating with the bal-
ance of fat consumption and oxidation.
Blood chemistries and liver lipid data of obese female WT, Mc4r/,
and Lepob/Lepob mice. After the completion of indirect calorimetry
experiments, all mice were returned to group housing (two per
cage) for 4–6 wk on the low-fat diet. Mice were then either
placed on the high-fat diet for 2 d, which was the period with
the greatest differences in RER between the strains, or left on the
low-fat diet (n  6 per group). FM and FFM were measured
after a 4-h fast, and tissues and sera were collected for analysis.
Group-housed Mc4r/ and Lepob/Lepob mice were hy-
perphagic compared with WT, irrespective of diet (data not
shown). FM as a percent of total body weight did not change
in WT mice and increased by 7% in Mc4r/ mice and 11% in
Lepob/Lepob mice (data not shown).
Blood chemistries for WT and obese Mc4r/ and Lepob/
Lepob mice are shown in Table 3. Both Mc4r/ and Lepob/
Lepob mice were hyperinsulinemic, although the increase was
significant only for Lepob/Lepob mice (P  0.05 compared with
WT and Mc4r/ mice). The lower fasting insulin in obese
Mc4r/ mice compared with obese Lepob/Lepob mice might
be due to a more severe obesity or, alternatively, the increase
in corticosterone associated with leptin deficiency. Hyper-
corticosteronemia is a significant factor in the insulin-resis-
tant phenotype of leptin-deficient mice (41) and is not ob-
served in Mc4r/ mice (24). Diet had a significant effect on
serum insulin (two-way ANOVA, P  0.01), with a 2- to
3-fold increase in fasting insulin observed in Mc4r/ and
Lepob/Lepob mice on the high-fat diet compared with the low-
fat diet. Blood glucose levels were normal in Lepob/Lepob mice
FIG. 3. Higher RER in Mc4r/ mice, relative to WT and Lepob/
Lepob mice, in response to high-fat (HF) diet is associated with a
higher RER to FQ ratio, weight gain, and an imbalance in FA me-
tabolism. (A) Analysis of the data as 4-h bins showed that RER ranged
between 0.9 and 1.1 on the low-fa (LF) data and was similar between
genotypes. Introduction of the HF diet resulted in a decline in the RER
irrespective of genotype; however, the RER of Mc4r/ mice was
higher over the first 2 d. Comparison of the ratio of RER to FQ
(RER/FQ) (B, D) with weight gain (C), and the balance (Bal.) of
nutrient consumption (Int.) and oxidation (Oxidn) (E). Weight gain
correlates with the RER to FQ ratio, with weight gain observed when
the RER to FQ ratio is greater than 1 (analysis of weight gain by
two-way ANOVA: genotype, P  0.185; diet, P  0.018; genotype 
diet, P  0.06; analysis of RER to FQ ratio by two-way ANOVA:
genotype, P  0.071; diet, P  0.001; genotype  diet, P  0.179;
*, significantly different from LF within genotype, P  0.05; a, sig-
nificantly different from WT between genotype, P  0.05). For the 3 d
on the HF diet, weight gain correlated with the balance of fat con-
sumption with FA oxidation (compare C with E). A negative balance
of fat consumption and FA oxidation observed in WT mice was as-
sociated with weight loss, whereas a positive balance of fat consump-
tion to FA oxidation observed in Mc4r/ mice was associated with
weight gain (*, significantly different from intake within genotype,
P  0.01). Carbohydrate consumption and oxidation were balanced
irrespective of genotype.
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compared with WT, which agrees with earlier studies show-
ing euglycemia in older animals (42, 43). Mc4r/ mice
exhibited a significant but small (30 point) increase in blood
glucose (P  0.01 compared with Lepob/Lepob and WT mice).
Serum free FA levels were not significantly different between
strain. On low-fat diet, serum TG levels were lower in Mc4r/
mice compared with WT mice. Serum nonesterified FA
(NEFA), TG, and glucose levels were not affected by diet. Liver
TG content was increased in Mc4r/ and Lepob/Lepob mice to
a comparable extent, with no effect of diet (Fig. 4)
Hepatic gene expression and protein levels in obese female WT,
Mc4r/, and Lepob/Lepob mice. The expression of genes in-
volved in lipogenesis and TG synthesis [SREBP1, FAS, and
acylcoenzyme A:diacylglycerol acyltransferase (DGAT) 2;
Fig. 5, A–C] and FA oxidation (PPAR, CPT1a, and AOX; Fig.
5, D and F) was examined using quantitative RT-PCR. ACC,
FAS, SREBP1, PPAR, and IRS2 protein levels were also
examined by Western blot analysis (Fig. 6).
Analysis of gene expression data using two-way ANOVA
revealed that diet had no significant effect on the expression of
lipogenic or oxidative genes. Genotype had no effect on the
expression of SREBP1 mRNA (Fig. 5A) or protein levels (Fig. 6).
In liver of Mc4r/ mice, FAS mRNA levels were increased 7-
to 10-fold compared with WT mice (P  0.001) and 2- to 3-fold
compared with Lepob/Lepob mice (P  0.001) (Fig. 5B). The greater
increase in FAS mRNA expression in Mc4r/ mice compared
with Lepob/Lepob mice correlated with changes in FAS protein
levels, which were highest in Mc4r/ mice (Fig. 6). The level
of ACC protein, which catalyzes the first step in FA biosyn-
thesis, was also increased in liver of Mc4r/ and Lepob/Lepob
mice compared with WT mice (Fig. 6). DGAT2 mRNA, which
encodes an enzyme involved in the final step of TG synthesis,
was increased in Mc4r/ and Lepob/Lepob mice but was not
significantly different on the low-fat diet (Fig. 5C). DGAT2
mRNA expression levels were increased by exposure to a high-
FIG. 4. Genetic background effects on the development of hepatic
steatosis in Mc4r/ mice. Preobese Mc4r/ mice (6 and 11 wk
old) in the B6 background do not exhibit hepatic steatosis, whereas
preobese Mc4r/ mice in the BSw;129 background exhibit severe
hepatic steatosis at 9 wk of age. Liver TG content was measured in
B6 Mc4r/ mice in the B6 background at various ages (left) and in
BSw;129 Mc4r/ mice at 9 wk of age (right). F6, 6-wk-old female
mice; M6, male 6-wk-old mice; M11, male 11-wk-old mice; F20L,
5-month-old obese female mice fed a purified low-fat diet; F20H,
5-month-old obese female mice fed a purified high-fat diet for 48 h;
M9L, 9-wk-old BSw;129 mice fed low-fat diet; M9H, 9-wk-old BSw;129
mice fed high-fat diet. *, P  0.05 compared with WT.
FIG. 5. Expression of genes involved in FA and TG synthesis (A–C)
and FA oxidation (D, F) in liver of WT controls, obese Mc4r/ (KO),
and obese Lepob/Lepob mice (OB). Mice were fed the purified low-fat
diet (open bars) or a purified high-fat diet for 48 h (solid bars). Blood
chemistries for these mice are shown in Table 3. Statistical analysis
used a two-way ANOVA (effects of genotype: a, P  0.001 compared
with WT and Lepob/Lepob; b, P  0.05 compared with WT; c, P  0.05
compared with WT and Lepob/Lepob; effects of diet: *, P  0.05 com-
pared with low-fat diet.
TABLE 3. Blood chemistries of WT, obese Mc4r/, and obese Lepob/Lepob mice
WT Mc4r/ Lepob/Lepob
Two-way ANOVA (P)
LF HF LF HF LF HF
Insulin (pg/ml) 76  31 96  16 808  369 1911  554 2186  489 6725  976 Diet, 0.01
Genotype, 0.01
Glucose (mg/dl) 128  3 131  6 162  9 172  14 149  7 137  11 Diet, NS
Genotype, 0.01
NEFA (mEq/liter) 0.54  0.08 0.84  0.18 0.80  0.11 0.60  0.07 0.84  0.18 0.72  0.11 Diet, NS
Genotype, NS
TG (mmol/liter) 2.8  0.6 2.2  0.3 1.4  0.2 1.7  0.2 1.9  0.3 2.3  0.3 Diet, NS
Genotype 0.05
LF, Low-fat; HF, high-fat; NS, not significant.
Mice were either fed a purified LF diet or fed a purified HF diet for 48 h. Mice were fasted for 4 h before the collection of serum samples.
Statistical analysis used a two-way ANOVA, with diet and genotype as the independent variables.
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fat diet (P  0.05), perhaps as the result of increased stimulation
by insulin (44).
There was a 2- to 3-fold increase in the expression of genes
involved in FA oxidation (PPAR, CPT1a, and AOX) in liver
of Lepob/Lepob mice compared with WT and Mc4r/ mice
(Fig. 5, D–F). Analysis of PPAR protein levels by Western
blot analysis confirmed that the increase in PPAR mRNA
resulted in increased protein levels in Lepob/Lepob mice com-
pared with both WT and Mc4r/ mice (Fig. 6).
An age-dependent increase expression of PPAR mRNA
in liver of obese Lepob/Lepob mice has been reported previ-
ously and is also observed in obese serotonin 2C receptor
knockout mice (45). Our observation that the age-dependent
increased expression of PPAR and PPAR-regulated genes
does not occur in obese Mc4r/ mice might indicate a role
for this receptor in what could be an adaptive response to
obesity. In addition, the increased expression of a lipogenic
gene (FAS) and reduced expression of oxidative genes in the
liver of Mc4r/ mice compared with Lepob/Lepob mice cor-
relate with differences in the thermogenic and substrate ox-
idation observed in these two obese strains in response to a
high-fat diet (Figs. 1–3). The increased expression of FA ox-
idative genes appears to correlate with the robust thermo-
genic response and the higher rate of FA oxidation of Lepob/
Lepob mice relative to Mc4r/ mice. It is also possible that
lipogenesis is reduced in obese Lepob/Lepob mice compared
with obese Mc4r/ mice.
The regulation of FAS mRNA expression is complex, involv-
ing numerous nuclear transcription factors (SREBP1c, liver X
receptor, insulin-induced gene, and PPAR) that respond to
insulin, sterols, and carbohydrate levels (46–48). Hyperinsu-
linemia stimulates the expression of lipogenic genes in liver
through SREBP1c and possibly PPAR (49–51). Hyperinsulin-
emia also suppresses IRS2 transcription, leading to a reduced
ability of insulin to suppress hepatic glucose output while si-
multaneously stimulating lipogenesis (51, 52). IRS2 protein lev-
els were reduced to a similar extent in Mc4r/ and Lepob/Lepob
mice, suggesting that hyperinsulinemia in both strains is asso-
ciated with reduced signaling through IRS2 (Fig. 5).
The 10-fold increase in FAS mRNA in the liver of Mc4r/
mice is interesting in that the increase was 3-fold greater than
that observed in Lepob/Lepob mice, and it also does not appear to
involve an increase inSREBP1 mRNA or protein (Figs. 5 and 6).
Overall, a different pattern of the changes was observed in
hepatic gene expression in obese Mc4r/ and Lepob/Lepob mice.
In Mc4r/ mice, a key lipogenic gene (FAS) is increased nearly
10-fold. In contrast, in Lepob/Lepob mice, there is an increase in the
expression of a group of genes involved in FA oxidation
(PPAR, AOX, and CPT1a). The increase in FAS mRNA in the
liver of obese Mc4r/ mice compared with obese Lepob/Lepob
mice might be due to differences in nuclear SREBP1c, which
were not measured in this study. Whether the changes in gene
expression are due to a specific role for the MC4R in suppress-
ing liver FAS expression and increasing PPAR activity or,
alternatively, are due to local differences in liver metabolism in
situations of obesity was not determined in this study. It is also
important to note that the differences in hepatic gene expression
between Mc4r/ and Lepob/Lepob mice were not associated
with changes in liver TG levels. This could indicate differences
in the equilibrium of FAs between the liver and extrahepatic
peripheral tissues.
Experiment 2: analysis of metabolism in preobese
Mc4r/ mice
FAS mRNA expression is not increased in preobese Mc4r/
mice. Older Mc4r/ mice exhibit an increase in FAS mRNA
expression and a reduction in IRS2 protein that is similar to
that reported in other mouse models of insulin resistance. We
examined the extent to which the changes in hepatic gene
expression were due to prolonged hyperinsulinemia, as op-
posed to a specific response to a reduction in MC4R activity,
by comparing FAS mRNA expression in preobese Mc4r/
and WT mice. Six-week-old female Mc4r/ (n  4),
Mc4r/ (n  6), and Mc4r/ (n  5) mice were fasted
overnight and then refed a purified low-fat diet for 3 h. Before
refeeding, FFM and FM were measured by NMR. After
refeeding, mice were anesthetized by brief exposure to CO2
before euthanasia. The data shown are from female mice,
similar results were observed in males.
At 6 wk of age, Mc4r/ mice were significantly larger than
their WT littermates; however, the difference was not due to an
exclusive increase in FM (Fig. 7). Food intake over the 3-h
refeeding period was not significantly different. Blood chem-
istry (insulin, leptin, glucose, and NEFA) were also not signif-
icantly different (Fig. 7). Liver TG content was significantly
increased in preobese female Mc4r/ mice (Fig. 4). However,
the magnitude of the increase in liver TG in preobese female
Mc4r/ males was mild when compared with that observed
in older obese Mc4r/ mice. Moreover, liver TG levels were
normal in male Mc4r/ mice at 6 wk and 11 wk of age. Liver
FIG. 6. Levels of ACC, FAS, SREBP1, PPAR, IRS2, and p65 (used
as a loading control) proteins in liver of Mc4r/ and Lepob/Lepob
mice compared with WT controls. An increase in FAS and ACC protein
in Mc4r/ and Lepob/Lepob mice compared with WT controls was
not associated with an increase in SREBP1, consistent with the
mRNA data shown in Fig. 5. PPAR protein levels were increased in
livers of Lepob/Lepob mice compared with Mc4r/ and WT mice,
which is also consistent with mRNA expression data shown in Fig. 5.
The upper band in the SREBP1 blot represents the full-length form;
the lower band represents the proteolytically cleaved transcription-
ally active N terminus of SREBP1. For ACC, FAS, SREBP1, and
PPAR, two samples from individual mice fed the low- or high-fat
diets are shown. For IRS2 and p65, three samples from mice fed the
low-fat diet are shown.
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FAS mRNA expression was not significantly different in
preobese 6-wk-old female Mc4r/ mice (Fig. 7) or in 6-wk or
11-wk-old male Mc4r/ mice (data not shown). Overall, the
data suggest that the development of hepatic steatosis in
Mc4r/ mice in the B6 background is likely to be secondary
to hyperinsulinemia associated with obesity.
Preobese Mc4r/ in the BSw;129 background can exhibit hepatic
steatosis without fasting hyperinsulinemia. Genetic background
can have a marked effect on the genotype of transgenic, knock-
out mice and spontaneous mutant mice (53, 54). To determine
whether genetic background has an effect on the development
of insulin resistance, we examined the phenotype of BSw;129
Mc4r/ mice. We used male BSw;129 Mc4r/ mice aged 8
wk that had been fed the purified low-fat diet or a purified very
high-fat diet (D12492, 60% kJ from fat) for 5 d. FFM was not
significantly different in BSw;129 Mc4r/ and BSw;129
Mc4r/ mice at this age and in this strain (data not shown).
On the low-fat diet, FM was similar in BSw;129 Mc4r/ and
BSw;129 Mc4r/ mice (FM as a percent of total body weight:
BSw;129 Mc4r/, 18.2  1.1%; BSw;129 Mc4r/, 16.0 
1.5%). On the high-fat diet, FM was significantly higher in
BSw;129 Mc4r/ mice compared with BSw;129 Mc4r/
mice (FM as a percent of total body weight: BSw;129 Mc4r/,
23.6  2.3%; BSw;129 Mc4r/, 18.0  1.8%).
Liver and serum were collected from mice that had been
fasted for 4 h. Unlike 6-wk and 11-wk-old Mc4r/ mice in the
B6 background, a marked increase in liver TG was observed in
BSw;129 Mc4r/ mice compared with WT Bsw;129 mice
(Fig. 4). Liver TG levels in BSw;129 Mc4r/ mice that were fed
the high-fat diet were also significantly increased compared
with the levels observed in BSw;129 Mc4r/ mice fed the
low-fat diet (P  0.01). Hepatic steatosis in BSw;129 Mc4r/
mice does not appear to be secondary to obesity or hyper-
insulinemia. The accumulation of TG in preobese BSw;129
Mc4r/ mice indicates defects in hepatic FA uptake, FA oxi-
dation, and/or TG secretion in this strain.
The large increase in liver TG would be predicted to be
associated with fasting hyperinsulinemia and hyperglyce-
mia. However, this was not the case in most of the BSw;129
Mc4r/ mice examined. Overall, two groups of BSw;129
Mc4r/ mice could be distinguished based on fasting in-
sulin and the expression of SREBP1 and FAS mRNA in liver.
Data from a representative selection of individual BSw;129
Mc4r/ and BSw;129 Mc4r/ mice are shown in Fig. 8.
The majority of BSw;129 Mc4r/ mice (nine of 11 mice)
had fasting serum insulin levels in the normal range (562 
67 pg/ml compared with 478  31 pg/ml for BSw;129
Mc4r/ mice, P  0.3). Because diet did not have a sig-
nificant effect on serum insulin, the data from the low-fat and
high-fat diet groups were pooled for this analysis. The BSw;
129 Mc4r/ mice with normal insulin levels also had nor-
mal expression of SREBP1 and FAS mRNA (data not shown),
which was also observed in preobese Mc4r/ mice in the
B6 background. Two BSw;129 Mc4r/ mice, which hap-
pened to be from the group fed the low-fat diet, did have
fasting hyperinsulinemia, with insulin levels of 2362 and
1417 pg/ml. Fasting hyperinsulinemia did not correlate with
FIG. 7. Preobese Mc4r/ and Mc4r/ mice in the B6 background
are not hyperinsulinemic or hyperglycemic and have normal levels of
leptin and NEFA. Liver FAS mRNA expression is not significantly
different in the absence of hyperinsulinemia. Hepatic steatosis and
increased FAS mRNA and protein expression observed in older B6
Mc4r/ mice (Figs. 4–6) is, therefore, probably secondary to obe-
sity-induced hyperinsulinemia.
FIG. 8. Western blot of IRS1 and IRS2 protein, serum insulin, liver
TG, and hepatic SREBP1 and FAS mRNA expression for individual
preobese BSw;129 Mc4r/ and BSw;129 Mc4r/ mice. In this
figure, it is apparent that IRS2 protein levels are not reduced in
preobese BSw;129 Mc4r/ mice. In addition, hepatic steatosis in
some preobese BSw;129 Mc4r/ mice is associated with fasting
insulin in the normal range. Overall, fasting insulin correlates with
hepatic SREBP1 and FAS mRNA but not with liver TG. This suggests
that the development of hepatic steatosis in this model occurs before
the development of fasting hyperinsulinemia. Western blots of IRS1,
IRS2, and p65 (a loading control) are compared with serum insulin,
liver TG, and hepatic SREBP1 and FAS mRNA expression for indi-
vidual animals. The arrow points to a preobese BSw;129 Mc4r/
mouse fed a purified high-fat (HF) diet and is included for reference.
LF, Low-fat diet; CYC, cyclophilin B.
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higher levels of liver TG compared with other BSw;129
Mc4r/ mice, ranging from 107–162 mg/g (Fig. 8). However,
SREBP1 and FAS mRNA levels were higher in the two hyper-
insulinemic BSw;129 Mc4r/ mice, with the increase in
SREBP1 and FAS mRNA proportional to insulin levels (Fig. 8).
On the low-fat diet, fasting blood glucose levels were
moderately increased in BSw;129 Mc4r/ mice compared
with BSw;129 Mc4r/ mice (blood glucose: BSw;129
Mc4r/, 129  8 mg/dl; BSw;129 Mc4r/, 100  6 mg/
dl). The very high-fat diet increased blood glucose 20–30
points in both BSw;129 Mc4r/ and BSw;129 Mc4r/
mice (BSw;129 Mc4r/, 165  8 mg/dl; BSw;129 Mc4r/,
121  6 mg/dl). Analysis using two-way ANOVA indicates
that the effects of diet and genotype on fasting blood glucose
are significant (P  0.01); there was no effect of genotype
on the effect of diet (genotype X diet, P  0.264). The mild
increases in fasting glucose associated with the high-fat diet
and loss of MC4R signaling might indicate increased hepatic
glucose output or insulin resistance in extrahepatic tissues.
IRS2 protein levels are normal in steatotic livers of preobese BSw;
129 Mc4r/ mice. In Lepob/Lepob and lipodystrophic mice,
hepatic steatosis is associated with hepatic insulin resistance,
with a reduction in IRS2 protein and an increase in SREBP1
and FAS (51, 55). So far, our data indicate that a dramatic
increase in liver TG can occur in BSw;129 Mc4r/ mice that
is not necessarily dependent on increased SREBP1 or FAS ac-
tivity. To examine whether the increase in hepatic SREBP1 and
FAS mRNA observed in the two hyperinsulinemic BSw;129
Mc4r/ mice is also associated with reduced insulin signal-
ing, we examined IRS1 and IRS2 protein by Western blot anal-
ysis (Fig. 8). Overall, IRS1 and IRS2 protein levels appeared to
be increased, not reduced, in liver of BSw;129 Mc4r/ mice
compared with BSw;129 Mc4r/ mice. Hepatic steatosis in
preobese BSw;129 Mc4r/ is thus distinguishable from that
observed in Lepob/Lepob and lipodystrophic mice in that it is not
necessarily associated with elevated FAS or reduced IRS2.
Discussion
Overall, the major findings of these experiments fall into two
areas. First, obese Mc4r/ mice have a significant reduction
in EE adjusted for FFM when compared with obese Lepob/Lepob
mice. The differences in EE of obese Lepob/Lepob mice compared
with obese Mc4r/ mice correlate with changes in the ex-
pression of genes involved in FA oxidation in liver. Second, we
have observed a significant effect of genetic background on the
development of hepatic steatosis in Mc4r/ mice. In the ma-
jority of BSw;129 Mc4r/ mice, the 10- to 20-fold increase in
liver TG was not associated with fasting hyperinsulinemia or
increased FAS mRNA expression. The results from experiment
2 suggest that the development of hepatic steatosis in Mc4r/
can in some circumstances occur independently of an increase
in lipogenic gene expression and could involve defects in FA
uptake and oxidation or TG secretion. In contrast, hepatic ste-
atosis in Lepob/Lepob and lipodystrophic models of insulin resis-
tance develops rapidly and is thought to be at least partially due
to increased transcription of lipogenic genes in response to
hyperinsulinemia (51, 55, 56).
The comparison of calorimetry data between lean and obese
strains can be difficult to interpret. Adjusting EE for FFM as-
sumes that FM has a negligible metabolic rate. However, it is
important to note that the Mc4r/ and Lepob/Lepob mice used
for indirect calorimetry in the present study were both obese.
If FM has a significant contribution to total-body EE, we would
have expected differences in EE to correlate with the differences
in FM observed between genotypes (WT  Mc4r/  Lepob/
Lepob). This was not the case, and in fact, EE appeared to be
reduced in Mc4r/ mice not only compared with Lepob/Lepob
mice but also compared with WT controls.
The mechanism explaining the increase in EE of Lepob/Lepob
mice remains unclear, although an increase in the expression of
FA oxidative genes in liver might be a contributing factor.
Hyperphagia is one possible cause for the increased metabolic
rate of Lepob/Lepob mice compared with WT and Mc4r/ mice
on the purified low-fat diet. However, it is interesting to observe
that on the high-fat diet, where energy consumption was equal,
Lepob/Lepob mice were still hypermetabolic compared with
Mc4r/ mice. One possibility is that the increased metabolic
rate in obese Lepob/Lepob mice might at least partially represent
a long-term adaptation to obesity similar to that reported in
some clinical studies of obese subjects (38).
Finally, the diabetic phenotype of Mc4r/ mice in the B6
background is very mild when compared with that reported for
mice in a mixed 129;B6 background. This observation is perhaps
not surprising when the effects of genetic background on the
development of DM2 in Lepob/Lepob mice is taken into consid-
eration. Lepob/Lepob mice in the B6 background are able to main-
tain normal glucose levels by increasing insulin output from an
increased population of  cells, whereas Lepob/Lepob mice in
other backgrounds develop severe DM2 (43, 54).
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